Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice

OBJECTIVE: The purpose of this study was to investigate the therapeutic effects of genetically modified mesenchymal stem cells (MSCs) in the treatment of type 2 diabetes mellitus (T2DM) in order to identify a new method for treating diabetes that differs from traditional medicine and to provide a ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Binghua, Xiao, Xiuxiao, Yu, Tingting, Xiao, Xinhua, Xie, Jing, Ji, Qiuhe, Wang, Li, Na, Tao, Meng, Shufang, Qian, Lingjia, Duan, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885588/
https://www.ncbi.nlm.nih.gov/pubmed/33588950
http://dx.doi.org/10.1186/s13287-021-02205-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885588/
https://www.ncbi.nlm.nih.gov/pubmed/33588950
http://dx.doi.org/10.1186/s13287-021-02205-z

Ejemplares similares